Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01405794 · ClinicalTrials.gov registry record · Phase 1
In-Vivo Assessment of Silver Biomaterial Nano-Toxicity 32 Ppm
A Phase 1 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT01405794 is a Phase 1 study that has completed, run by University of Utah. The registered enrollment target is 12 participants.
The verdict
NCT01405794, a Phase 1 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The investigators propose to study oral commercial silver nanoparticle products on human enzyme activity.
Interventions
- DRUG Placebo
- DRUG 32ppm Silver Particle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2011-07 |
| Est. Completion | 2011-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01405794
The ClinicalTrials.gov registry entry for NCT01405794 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01405794 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01405794 about?
NCT01405794 is a clinical study titled "In-Vivo Assessment of Silver Biomaterial Nano-Toxicity 32 Ppm". The investigators propose to study oral commercial silver nanoparticle products on human enzyme activity.
What is the current status of trial NCT01405794?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2011-07. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01405794?
The interventions under investigation include: Placebo (DRUG), 32ppm Silver Particle (DRUG).
Who is sponsoring clinical trial NCT01405794?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.